Work

Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?

Year: 2020

Type: letter

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.20.00702

Authors: Lawrence H. Einhorn, Nabil Adra, Nasser Hanna, Craig Nichols

Institutions: Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Genentech

OpenAlex ID: W3040270011

Cites: 9

Cited by: 2

Related to: 10